These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34508956)

  • 21. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenic cell death in cancer therapy: Present and emerging inducers.
    Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
    J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment.
    Zhu S; Wang Y; Tang J; Cao M
    Front Immunol; 2022; 13():1074477. PubMed ID: 36532071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of immunogenic cell death and immune checkpoint blockade therapy.
    Lin RA; Lin JK; Lin SY
    Kaohsiung J Med Sci; 2021 Jun; 37(6):448-458. PubMed ID: 33636043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor.
    Jiang Q; Zhang C; Wang H; Peng T; Zhang L; Wang Y; Han W; Shi C
    Front Oncol; 2019; 9():1196. PubMed ID: 31781498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A bio-responsive, cargo-catchable gel for postsurgical tumor treatment via ICD-based immunotherapy.
    Chen Q; Zhou S; Ding Y; Chen D; Dahiru NS; Tang H; Xu H; Ji M; Wang X; Li Z; Chen Q; Li Y; Tu J; Sun C
    J Control Release; 2022 Jun; 346():212-225. PubMed ID: 35461965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.
    Wang Z; Chen L; Ma Y; Li X; Hu A; Wang H; Wang W; Li X; Tian B; Dong J
    J Nanobiotechnology; 2021 Aug; 19(1):243. PubMed ID: 34384429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs.
    Nel AE; Mei KC; Liao YP; Liu X
    ACS Nano; 2022 Apr; 16(4):5184-5232. PubMed ID: 35348320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic Reinforcing of Immunogenic Cell Death and Transforming Tumor-Associated Macrophages Via a Multifunctional Cascade Bioreactor for Optimizing Cancer Immunotherapy.
    Huang C; Lin B; Chen C; Wang H; Lin X; Liu J; Ren Q; Tao J; Zhao P; Xu Y
    Adv Mater; 2022 Dec; 34(51):e2207593. PubMed ID: 36245299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy.
    Shi M; Zhang J; Wang Y; Han Y; Zhao X; Hu H; Qiao M; Chen D
    Acta Biomater; 2022 Sep; 150():353-366. PubMed ID: 35843594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor microenvironment-responsive delivery nanosystems reverse immunosuppression for enhanced CO gas/immunotherapy.
    Chen B; Guo K; Zhao X; Liu Z; Xu C; Zhao N; Xu FJ
    Exploration (Beijing); 2023 Dec; 3(6):20220140. PubMed ID: 38264682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
    Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
    Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MnO
    Ding B; Zheng P; Jiang F; Zhao Y; Wang M; Chang M; Ma P; Lin J
    Angew Chem Int Ed Engl; 2020 Sep; 59(38):16381-16384. PubMed ID: 32484598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade.
    Zhao Z; Dong S; Liu Y; Wang J; Ba L; Zhang C; Cao X; Wu C; Yang P
    ACS Nano; 2022 Dec; 16(12):20400-20418. PubMed ID: 36441901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy.
    Shim MK; Song SK; Jeon SI; Hwang KY; Kim K
    Expert Opin Drug Deliv; 2022 Jun; 19(6):641-652. PubMed ID: 35603410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research progress in inducing immunogenic cell death of tumor cells.
    Xie D; Wang Q; Wu G
    Front Immunol; 2022; 13():1017400. PubMed ID: 36466838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy.
    Huang G; Liu L; Pan H; Cai L
    Small Methods; 2023 May; 7(5):e2201412. PubMed ID: 36572642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
    Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
    ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled Refolding of Denatured IL-12 Using In Situ Antigen-Capturing Nanochaperone Remarkably Reduces the Systemic Toxicity and Enhances Cancer Immunotherapy.
    Zhang Y; Ma F; Chen J; Chen Y; Xu L; Li A; Liu Y; Ma R; Shi L
    Adv Mater; 2024 May; 36(19):e2309927. PubMed ID: 38387609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.